Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-18

Clinical Trial Update: Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing octreotide to loperamide for chemotherapy-related diarrhea in colorectal cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loperamide (loperamide)
  • OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Colorectal Cancer, Diarrhea | Phase 3 | Status: COMPLETED